Interferon-β-1b
Transcript of Interferon-β-1b
Reactions 1471, p28 - 28 Sep 2013
SInterferon-β-1b
Autoimmune polyendocrine syndrome: case reportA 37-year-old man with multiple sclerosis and Grave’s
disease was diagnosed with autoimmune polyendocrinesyndrome type 3, after developing type 1 diabetes mellituswhile receiving interferon-β-1b [dosage, route and duration oftherapy to onset of reaction, and outcome not stated].
Author comment: "In our patient, type 1 diabetes mellitusseemed to be induced by restarting interferon-β-1b therapy.Our case suggested that. . . interferon-β-1b therapy for an MSpatient with a specific genetic background may induce onsetof type 1 diabetes mellitus."Masuda S, et al. Autoimmune polyendocrine syndrome type 3 with multiplesclerosis: Possible induction of type 1 diabetes by interferon-b1b therapy. Clinicaland Experimental Neuroimmunology 4: 134, No. 1, Jun 2013. Available from:URL: http://dx.doi.org/10.1111/cen3.12004 [abstract] - Japan 803093278
1
Reactions 28 Sep 2013 No. 14710114-9954/13/1471-0001/$14.95 Adis © 2013 Springer International Publishing AG. All rights reserved